NEW YORK (GenomeWeb) – Only one of the 21 genes reportedly linked to Brugada syndrome has enough supporting evidence for its inclusion in clinical genetic tests, according to a new analysis.

Brugada syndrome is arrhythmia condition that affects 1 in 2,000 people and can lead to sudden death. More than 20 genes have been reported to be associated with the condition, and many are included on Brugada syndrome gene panel tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.